LGALS3 and thyroid gland papillary carcinoma: Inhibition of gal-3 with Td131_1 demonstrated a synergistic effect with doxorubicin in a human ex vivo papillary thyroid cancer model by the activation of caspase 3 and PARP cleavage [56].